Reuters Pharma Japan 2022 - Pharma’s freedom to start anew

After 2 years of the pandemic, Reuters Pharma Japan 2022 is Back! "Reuters Events Pharma Japan is always at the forefront of the pharma industry’s next movement". AKT Health Analytics was proud to be partnered with Reuters Event Pharma Japan 2022 (28th and 29th of September). Where senior executives, thinkers, and transformers have showcased their dedication and imagination to pave the way for a new era of value and innovation for patients. 

Reuters Pharma event is the most influential forum for Japanese Pharma Leaders in Marketing, Commercial, Medical Affairs, RWE, and Clinical. Pharma Japan 2022, is a staple in senior-level pharma executives’ conference calendars. At this event, the AKTHealth team got an opportunity to showcase our AKTHealth services, Technology, solutions, and capabilities to the attendees. 

Reuters Japan 2022 was a very insightful event this year with many eminent speakers and attendees. There was a lot of learning and exchange of ideas that happened during the event. We would say it was a success. AKT Health team got an opportunity to meet people who understood our language and we were able to have meaningful discussions with those for who the domain was new. A successful event for Team AKT and Reuters Japan team as well. Post-pandemic, it is good to meet people personally and build more connections. We hope next year would be even better! said Rashmi Gurnani, Chief Executive Officer.

We hope to create value for the companies we met and be able to deliver better than what is expected from us. The people at Reuters was a bunch of intelligent people who know what they require in terms of services and we want to ensure that we successfully provide a solution to their objectives.

Reuters Pharma Japan 2022 has been successfully completed. AKTHealh Team is looking forward to seeing you next year 2023!

If you are interested in connecting with our AKT Health experts to learn more about our services, please contact us at info@akthealth.jp